- Home
- IMUX vs EVF Comparison
IMUX vs EVF Comparison
Compare IMUX & EVF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMUX
- EVF
- Stock Information
- Founded
- IMUX 2016
- EVF 1998
- Country
- IMUX United States
- EVF United States
- Employees
- IMUX N/A
- EVF N/A
- Industry
- IMUX Biotechnology: Pharmaceutical Preparations
- EVF Investment Managers
- Sector
- IMUX Health Care
- EVF Finance
- Exchange
- IMUX Nasdaq
- EVF Nasdaq
- Market Cap
- IMUX 107.3M
- EVF 102.2M
- IPO Year
- IMUX N/A
- EVF N/A
- Fundamental
- Price
- IMUX $0.69
- EVF $5.67
- Analyst Decision
- IMUX Strong Buy
- EVF
- Analyst Count
- IMUX 6
- EVF 0
- Target Price
- IMUX $11.60
- EVF N/A
- AVG Volume (30 Days)
- IMUX 1.4M
- EVF 93.3K
- Earning Date
- IMUX 05-15-2025
- EVF 01-01-0001
- Dividend Yield
- IMUX N/A
- EVF 10.68%
- EPS Growth
- IMUX N/A
- EVF N/A
- EPS
- IMUX N/A
- EVF 0.94
- Revenue
- IMUX N/A
- EVF N/A
- Revenue This Year
- IMUX N/A
- EVF N/A
- Revenue Next Year
- IMUX N/A
- EVF N/A
- P/E Ratio
- IMUX N/A
- EVF $6.74
- Revenue Growth
- IMUX N/A
- EVF N/A
- 52 Week Low
- IMUX $0.56
- EVF $5.20
- 52 Week High
- IMUX $2.11
- EVF $6.84
- Technical
- Relative Strength Index (RSI)
- IMUX 27.13
- EVF 50.78
- Support Level
- IMUX $0.56
- EVF $5.60
- Resistance Level
- IMUX $0.95
- EVF $5.68
- Average True Range (ATR)
- IMUX 0.07
- EVF 0.05
- MACD
- IMUX -0.03
- EVF -0.00
- Stochastic Oscillator
- IMUX 22.66
- EVF 42.31
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
About EVF Eaton Vance Senior Income Trust
Eaton Vance Senior Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide a high level of current income consistent with the preservation of capital, by investing in senior, secured floating-rate loans. The trust invests in below-investment-grade floating-rate loans, which are considered speculative because of the credit risk of their issuers. Its portfolio of investment consists of aerospace and defense, automotive, beverage, building and development, business equipment and services, cable and satellite television, and other areas.